Table 3.
pharmacokinetic parameters | Difference of Bayesian minus population (95% CI) | |||
---|---|---|---|---|
Errors | One-compartment linear elimination | Two-compartment linear elimination | One-compartment nonlinear elimination | |
CL/F | me | 0.063 (-0.13, 0.26) | 1.3 (-0.48, 3.2) | − |
mse | -0.92 (-1.87, 0.033) | -250 (-340, -160)* | − | |
Vdss/F | me | -0.25 (-1.6, 1.1) | 11 (1.0, 21) | -0.28 (-0.84, 0.27) |
mse | -44 (-93, 5.5) | -6400 (-8500, -4200)* | 0.60 (-3.8, 5.0) | |
Vc/F | me | − | 0.11 (-0.086, 0.30) | − |
mse | − | -2.1 (-3.5, -0.65)* | − | |
t½α | me | − | 0.047 (0.033, 0.062) | − |
mse | − | -0.0056 (-0.010, -0.0017)* | − | |
t½β | me | -1.3 (-3.5, 0.86) | 1.45 (0.419, 2.48)* | − |
mse | -42 (-92, 8.5) | 57 (-16, 130) | − | |
ka | me | -0.25 (-0.45, -0.050)* | -0.48 (-0.57, -0.40)* | -0.12 (-0.23, -0.020)* |
mse | -0.56 (-0.77, -0.36)* | 0.11 (-0.17, 0.39) | 0.041 (-0.13, 0.21) | |
Vmax | me | − | − | 0.034 (-0.54, 0.61) |
mse | − | − | -8.1 (-11, -5.5)* | |
km | me | − | − | -0.050 (-0.13, 0.028) |
mse | − | − | 0.0933 (-0.0307, 0.217) | |
CLint | me | − | − | 0.0408 (-0.112, 0.193) |
mse | − | − | -0.568 (-0.854, -0.282)* |
CL, clearance; Vdss, volume of distribution at steady state; Vc, volume of central compartment; t½α, distribution halflife; t½β, elimination half-life; ka, absorption rate constant; Vmax, maximum velocity; km, Michaelis-Menten constant; CLint, intrinsic clearance.